Hemorrhagic stroke: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*~10% of all acute strokes | |||
*Warfarin use is significant risk factor | |||
**Accounts for 5-15% of all cases | |||
**Risk of ICH doubles for each 0.5 increase in INR above 4.5 | |||
==Risk Factors== | |||
#HTN | |||
#AVM | |||
#Aneurysm | |||
#Anticoagulant therapy | |||
#Sympathomimetic drugs | |||
#Intracranial tumors | |||
#Amyloid angiopathy | |||
#Smoking | |||
==Clinical Features== | |||
*Often clinically indistinguishable from SAH, ischemic stroke | |||
**More likely to have rapidly progressive symptoms | |||
*HA and N/V often precede the neurologic deficit | |||
*Findings dictated by location of bleed (in order of most common) | |||
**Putamen | |||
**Thalamus | |||
**Pons | |||
**Cerebellum | |||
==Work-Up== | |||
*Head CT (non-con) | |||
*Labs | |||
**CBC | |||
**Chem | |||
**Coags | |||
**T&S | |||
*ECG | |||
==Management== | ==Management== | ||
#Elevating head of bed to 30 degrees (if pt not hypotensive) | #Elevating head of bed to 30 degrees (if pt not hypotensive) | ||
# | #Blood pressure | ||
# | ##SBP >200 or MAP >150 | ||
## | ###Consider aggressive reduction w/ continuous IV infusion | ||
## | ##SBP >180 or MAP >130 and evidence or suspicion of elevated ICP | ||
### | ###Consider reducing BP using intermittent or continuous IV meds to keep CPP >60-80 | ||
## | ##SBP >180 or MAP >130 and NO evidence or suspicion of elevated ICP | ||
### | ###Consider modest reduction of BP (e.g. MAP of 110 or target BP of 160/90) | ||
### | #Reverse coagulopathy | ||
### | ##Heparin | ||
##Prothrombin complex concentrate | ###Give protamine 1mg/100units of heparin based on time since last dose | ||
### | ##Warfarin | ||
# | ###Reverse regardless of INR | ||
##Desmopressin (0.3mcg/kg) | ###Prothrombin complex concentrate 20-50mg/kg IV x1 OR | ||
##Platelets | ###FFP + vit K 10mg IV over 10min | ||
##ASA/clopidogrel | |||
###Desmopressin (0.3mcg/kg) | |||
###Platelets | |||
==See Also== | ==See Also== | ||
[[SAH]] | *[[SAH]] | ||
*[[CVA]] | |||
==Source== | ==Source== | ||
EMcrit Podcast 17 | *Tintinalli | ||
*EMcrit Podcast 17 | |||
[[Category:Neuro]] | [[Category:Neuro]] | ||
Revision as of 06:30, 29 September 2011
Background
- ~10% of all acute strokes
- Warfarin use is significant risk factor
- Accounts for 5-15% of all cases
- Risk of ICH doubles for each 0.5 increase in INR above 4.5
Risk Factors
- HTN
- AVM
- Aneurysm
- Anticoagulant therapy
- Sympathomimetic drugs
- Intracranial tumors
- Amyloid angiopathy
- Smoking
Clinical Features
- Often clinically indistinguishable from SAH, ischemic stroke
- More likely to have rapidly progressive symptoms
- HA and N/V often precede the neurologic deficit
- Findings dictated by location of bleed (in order of most common)
- Putamen
- Thalamus
- Pons
- Cerebellum
Work-Up
- Head CT (non-con)
- Labs
- CBC
- Chem
- Coags
- T&S
- ECG
Management
- Elevating head of bed to 30 degrees (if pt not hypotensive)
- Blood pressure
- SBP >200 or MAP >150
- Consider aggressive reduction w/ continuous IV infusion
- SBP >180 or MAP >130 and evidence or suspicion of elevated ICP
- Consider reducing BP using intermittent or continuous IV meds to keep CPP >60-80
- SBP >180 or MAP >130 and NO evidence or suspicion of elevated ICP
- Consider modest reduction of BP (e.g. MAP of 110 or target BP of 160/90)
- SBP >200 or MAP >150
- Reverse coagulopathy
- Heparin
- Give protamine 1mg/100units of heparin based on time since last dose
- Warfarin
- Reverse regardless of INR
- Prothrombin complex concentrate 20-50mg/kg IV x1 OR
- FFP + vit K 10mg IV over 10min
- ASA/clopidogrel
- Desmopressin (0.3mcg/kg)
- Platelets
- Heparin
See Also
Source
- Tintinalli
- EMcrit Podcast 17
